monkeypox treatment

Tecovirimat-resistant mpox has emerged as a concerning public health issue in the United States, with a recent cluster of cases highlighting the challenges posed by this drug-resistant variant of the monkeypox virus (MPXV).Health authorities have identified that all reported mpox cases in this cluster involved individuals with no documented history of prior tecovirimat treatment, raising alarm over the potential for drug resistance to develop.